Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pop-Busui R et al. - Treatment with glyburide, but not rosiglitazone, resulted in a significant deterioration in both resting and stress MBF. Rosiglitazone, but not glyburide, ameliorated markers of nitrosative stress and inflammation in subjects with T2DM without impairing myocardial perfusion.

Related Articles

Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09    Relevance Score: 96%

Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 10/19/09    Relevance Score: 95%

Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study
Clinical Endocrinology, 10/16/09    Relevance Score: 94%

Periodontal Disease – The Overlooked Diabetes Complication
Nephrology Nursing Journal, 10/07/09    Relevance Score: 94%

Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes
Diabetic Medicine, 10/05/09    Relevance Score: 94%

Today in Clinical Pharmacology...keeping you current

Dienogest: a new therapeutic agent for the treatment of endometriosis
Women's Health, 12/18/09

ACC, AHA Update Guidelines for Beta Blockers
American Family Physician, 12/17/09

Erythromycin Ophthalmic Ointment Supply Increasing
American Family Physician, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address